Aarkstore - Fecal Incontinence-Pipeline Insights, 2014

1
Fecal Incontinence-Pipeline Insights,
2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77060/-fecal-i
  ncontinence-pipeline-insights-2014

2
Summary

• DelveInsights, Fecal Incontinence-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  indication. A key objective of the report is to
  establish the understanding for all the pipeline
  drugs that fall under Fecal Incontinence. This
  report provides information on the therapeutic
  development based on the Fecal Incontinence
  dealing with all the pipeline drugs, comparative
  analysis at various stages covering Filed, Phase
  III, Phase II, Phase I, IND filed, Preclinical,
  Discovery and unknown stages, therapeutics
  assessment by monotherapy and combination
  products and molecule type drug information. The
  report also covers the companies information
  involved in the therapeutic development of the
  products. It also has highlighted the
  discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Fecal IncontinenceThe
  report provides pipeline products under drug
  profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the Fecal Incontinence
  pipeline on the basis of target, MOA, route of
  administration, technology involved and molecule
  typeThe report reviews key players involved in
  the therapeutics development for Fecal
  Incontinence and also provide company
  profilingThe report also gives the information
  of dormant and discontinued pipeline
  projects Pipeline products coverage based on
  various stages of development ranging from
  preregistration till discovery and undisclosed
  stages Provides pipeline assessment by
  monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for Fecal IncontinenceIdentify the
  relationship between the drugs and use it for
  target finding, drug repurposing, and precision
  medicine.Devise corrective measures for pipeline
  projects by understanding Fecal Incontinence
  pipeline depth and focus of Indication
  therapeutics Developing strategic initiatives to
  support your drug development activities.Optimize
  your portfolio and keep you in touch with the
  rapidly changing pharmaceutical markets, and make
  the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipelineGaining a Full Picture of the
  Competitive Landscape for Evidence based
  DecisionsYou can order full Report with TOC and
  for Sample page visit _at_http//www.aarkstore.com/h
  ealthcare/77060/-fecal-incontinence-pipeline-insig
  hts-2014

7
Table of Content

• Fecal Incontinence Overview
• Fecal Incontinence Pipeline Therapeutics
• Fecal Incontinence Therapeutics under Development
  by Companies
• Fecal Incontinence Late Stage Products (Filed and
  Phase III)
• Comparative Analysis
• Fecal Incontinence Mid Clinical Stage Products
  (Phase II)
• Comparative Analysis
• Fecal Incontinence Early Clinical Stage Products
  (Phase I and IND Filed)
• Comparative Analysis
• Fecal Incontinence Discovery and Pre-Clinical
  Stage Products
• Comparative Analysis
• Drug Candidate Profiles

8
Table of Content

• Fecal Incontinence Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Fecal Incontinence Discontinued Products
• Fecal Incontinence Dormant Products
• Companies Involved in Therapeutics Development
  for Fecal Incontinence
• Appendix
• Methodology
• Contact Us
• Disclaimer

9
List of Tables

• Number of Products under Development for Fecal
  Incontinence, 2014
• Number of Products under Development by Companies
  
• Comparative Analysis by Late Clinical Stage
  Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products
  (Phase II), 2014
• Comparative Analysis Early Clinical Stage
  Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical
  Stage Products, 2014
• Drug Candidates Profiles
• Fecal Incontinence Assessment by Monotherapy
  Products
• Fecal Incontinence Assessment by Combination
  Products

10
List of Tables

• Fecal Incontinence Assessment by Route of
  Administration
• Fecal Incontinence Assessment by Stage and Route
  of Administration
• Fecal Incontinence Assessment by Molecule Type
• Fecal Incontinence Assessment by Stage and
  Molecule Type
• Fecal Incontinence Therapeutics Discontinued
  Products
• Fecal Incontinence Therapeutics Dormant Products
• Products under Development by Companies, 2014

11
List of Figures

• Number of Products under Development for Fecal
  Incontinence, 2014
• Late Clinical Stage Products (Filed and Phase
  III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND
  Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Fecal Incontinence Assessment by Monotherapy
  Products
• Fecal Incontinence Assessment by Combination
  Products
• Fecal Incontinence Assessment by Route of
  Administration
• Fecal Incontinence Assessment by Stage and Route
  of Administration
• Fecal Incontinence Assessment by Molecule Type
• Fecal Incontinence Assessment by Stage and
  Molecule Type

12
Related Reports

• 2015 Worldwide Medical Laboratories
  Industry-Industry Market Report
• 2015 Worldwide Pharmaceutical Preparation Mfg.
  Industry-Industry Market Report
• OncoPlex Diagnostics - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• MetaStat, Inc. - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Advanced Cell Diagnostics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• Fecal Incontinence-Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Fecal Incontinence-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  indication.
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news